| ISIN | CH0378452160 |
|---|---|
| Valor Number | 37845216 |
| Bloomberg Global ID | UBESPIX SW |
| Fund Name | UBS (CH) Institutional Fund - Equities Switzerland Passive Large Capped II I-X-acc |
| Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
| Fund Provider | UBS Asset Management Switzerland AG, Zurich |
| Representative in Switzerland | |
| Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 UBS AG, Zürich Zürich Phone: +41 44 234 11 11 |
| Asset Class | Equities |
| EFC Category | Equity Switzerland |
| Distribution Policy | Accumulation |
| Home Country | Switzerland |
| Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | n/a |
| Peculiarities |
| Current Price * | 1,826.47 CHF | 09.01.2026 |
|---|---|---|
| Previous Price * | 1,816.80 CHF | 08.01.2026 |
| 52 Week High * | 1,826.47 CHF | 09.01.2026 |
| 52 Week Low * | 1,454.11 CHF | 09.04.2025 |
| NAV * | 1,826.47 CHF | 09.01.2026 |
| Issue Price * | 1,826.47 CHF | 09.01.2026 |
| Redemption Price * | 1,826.47 CHF | 09.01.2026 |
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 141,272,867 | |
| Unit/Share Assets *** | 141,272,867 | |
| Trading Information SIX | ||
| YTD Performance | +1.16% |
31.12.2025 - 09.01.2026
31.12.2025 09.01.2026 |
|---|---|---|
| 1 month | +3.79% |
09.12.2025 - 09.01.2026
09.12.2025 09.01.2026 |
| 3 months | +6.44% |
09.10.2025 - 09.01.2026
09.10.2025 09.01.2026 |
| 6 months | +11.94% |
09.07.2025 - 09.01.2026
09.07.2025 09.01.2026 |
| 1 year | +16.10% |
09.01.2025 - 09.01.2026
09.01.2025 09.01.2026 |
| 2 years | +25.82% |
09.01.2024 - 09.01.2026
09.01.2024 09.01.2026 |
| 3 years | +28.89% |
09.01.2023 - 09.01.2026
09.01.2023 09.01.2026 |
| 5 years | +35.16% |
05.07.2022 - 09.01.2026
05.07.2022 09.01.2026 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Roche Holding AG | 16.30% | |
|---|---|---|
| Nestle SA | 15.53% | |
| Novartis AG Registered Shares | 15.49% | |
| UBS Group AG Registered Shares | 6.98% | |
| Compagnie Financiere Richemont SA Class A | 6.91% | |
| ABB Ltd | 6.88% | |
| Zurich Insurance Group AG | 6.38% | |
| Swiss Re AG | 3.19% | |
| Holcim Ltd | 3.01% | |
| Lonza Group Ltd | 2.92% | |
| Last data update | 30.11.2025 | |
| TER | 0.01% |
|---|---|
| TER date | 31.10.2024 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.01% |
|
SRRI ***
|
|
| SRRI date *** | 31.12.2025 |